Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?

Affiliations

¹ Departments of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry, University of Rochester School of Medicine and Dentistry, New York, Rochester, USA.
² Departments of Biostatistics and Computational Biology and Neurology, University of Rochester, New York, Rochester, USA.
³ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Robert H Dworkin et al. Clin Pharmacol Ther. 2023 Dec.

. 2023 Dec;114(6):1166-1169.

doi: 10.1002/cpt.3050. Epub 2023 Oct 5.

¹ Departments of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry, University of Rochester School of Medicine and Dentistry, New York, Rochester, USA.
² Departments of Biostatistics and Computational Biology and Neurology, University of Rochester, New York, Rochester, USA.
³ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

No abstract available

Comment in

Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes.
Ching THW, Shnayder S. Ching THW, et al. Clin Pharmacol Ther. 2024 Mar;115(3):400. doi: 10.1002/cpt.3129. Epub 2024 Jan 2. Clin Pharmacol Ther. 2024. PMID: 38168006 No abstract available.

1. Reiff, C.M. et al. Psychedelics and psychedelic-assisted psychotherapy. Am. J. Psychiatry 177, 391-410 (2020).
1. Goodwin, G.M., Malievskaia, E., Fonzo, G.A. & Nemeroff, C.B. Must psilocybin always “assist psychotherapy”? Am. J. Psychiatry, appiajp20221043 (2023). https://doi.org/10.1176/appi.ajp.20221043.
1. Nayak, S.M., Bradley, M.K., Kleykamp, B.A., Strain, E.C., Dworkin, R.H. & Johnson, M.W. Control conditions in randomized trials of psychedelics: an ACTTION systematic review. J. Clin. Psychiatry 84, 22r14518 (2023).
1. Dworkin, R.H. et al. If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics. J. Pain 23, 1666-1679 (2022).
1. U.S. Department of Health and Human Services. Psychedelic Drugs: Considerations for Clinical Investigations: Guidance for Industry, Draft Guidance (Food and Drug Administration). Rockville, MD (2023).